The US House Committee on Appropriation approved a $3.212 billion budget for the 2021 fiscal year. Part of the funding bill also gives the Food and Drug Administration authority to recall unsafe prescription and over-the-counter drugs. The proposed budget also includes a $31 million addition in response to the COVID-19 pandemic to help support the agency in reviewing new therapies and potentially vaccines. The bill will now move on for approval from the House of Representatives.
Read more here.
More on: News Regulatory